vs
Side-by-side financial comparison of Acadian Asset Management Inc. (AAMI) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Acadian Asset Management Inc. is the larger business by last-quarter revenue ($172.2M vs $158.6M, roughly 1.1× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 20.2%, a 51.0% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 2.6%).
United Asset Management was an American holding company headquartered in Boston, Massachusetts.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
AAMI vs STOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $172.2M | $158.6M |
| Net Profit | $34.7M | $112.9M |
| Gross Margin | — | — |
| Operating Margin | 33.3% | 70.2% |
| Net Margin | 20.2% | 71.2% |
| Revenue YoY | 2.6% | 3661.1% |
| Net Profit YoY | -18.4% | 528.0% |
| EPS (diluted) | $0.97 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $172.2M | — | ||
| Q3 25 | $144.2M | — | ||
| Q2 25 | $127.4M | — | ||
| Q1 25 | $119.9M | $158.6M | ||
| Q4 24 | $167.8M | $22.6M | ||
| Q3 24 | $123.1M | — | ||
| Q2 24 | $109.0M | — | ||
| Q1 24 | $105.7M | — |
| Q4 25 | $34.7M | — | ||
| Q3 25 | $15.1M | — | ||
| Q2 25 | $10.1M | — | ||
| Q1 25 | $20.1M | $112.9M | ||
| Q4 24 | $42.5M | $-10.5M | ||
| Q3 24 | $16.9M | — | ||
| Q2 24 | $11.0M | — | ||
| Q1 24 | $14.6M | — |
| Q4 25 | 33.3% | — | ||
| Q3 25 | 18.4% | — | ||
| Q2 25 | 12.7% | — | ||
| Q1 25 | 26.6% | 70.2% | ||
| Q4 24 | 38.7% | -60.4% | ||
| Q3 24 | 21.9% | — | ||
| Q2 24 | 18.9% | — | ||
| Q1 24 | 21.7% | — |
| Q4 25 | 20.2% | — | ||
| Q3 25 | 10.5% | — | ||
| Q2 25 | 7.9% | — | ||
| Q1 25 | 16.8% | 71.2% | ||
| Q4 24 | 25.3% | -46.4% | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 10.1% | — | ||
| Q1 24 | 13.8% | — |
| Q4 25 | $0.97 | — | ||
| Q3 25 | $0.42 | — | ||
| Q2 25 | $0.28 | — | ||
| Q1 25 | $0.54 | $1.90 | ||
| Q4 24 | $1.11 | $-0.15 | ||
| Q3 24 | $0.45 | — | ||
| Q2 24 | $0.29 | — | ||
| Q1 24 | $0.37 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $274.8M |
| Total DebtLower is stronger | $200.0M | — |
| Stockholders' EquityBook value | — | $350.1M |
| Total Assets | $677.0M | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $274.8M | ||
| Q4 24 | — | $128.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $200.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $275.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $350.1M | ||
| Q4 24 | — | $229.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $677.0M | — | ||
| Q3 25 | $751.4M | — | ||
| Q2 25 | $672.3M | — | ||
| Q1 25 | $677.3M | $406.9M | ||
| Q4 24 | $703.2M | $271.6M | ||
| Q3 24 | $555.2M | — | ||
| Q2 24 | $533.1M | — | ||
| Q1 24 | $544.9M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.4M | $131.8M |
| Free Cash FlowOCF − Capex | — | $131.7M |
| FCF MarginFCF / Revenue | — | 83.0% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | -0.07× | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.4M | — | ||
| Q3 25 | $-23.9M | — | ||
| Q2 25 | $61.6M | — | ||
| Q1 25 | $-48.8M | $131.8M | ||
| Q4 24 | $55.8M | $-23.2M | ||
| Q3 24 | $69.6M | — | ||
| Q2 24 | $45.7M | — | ||
| Q1 24 | $-40.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $131.7M | ||
| Q4 24 | — | $-23.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 83.0% | ||
| Q4 24 | — | -102.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -0.07× | — | ||
| Q3 25 | -1.58× | — | ||
| Q2 25 | 6.10× | — | ||
| Q1 25 | -2.43× | 1.17× | ||
| Q4 24 | 1.31× | — | ||
| Q3 24 | 4.12× | — | ||
| Q2 24 | 4.15× | — | ||
| Q1 24 | -2.77× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
